Evidence map›Paper›PMID 21071226›Full record

ReviewTrends in cell biology2011

Metastasis: tumor cells becoming MENAcing.

Frank Gertler, John Condeelis

Registry-linked trialAbstract readReview
In one paragraph

Review in Trends in cell biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03694756 (TMEM-MRI), which is not on this map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03694756 narecruitingnot on this mapstarted 2018, after this paper: background citation

TMEM-MRI: A Pilot Feasibility Study of Magnetic Resonance Imaging for Imaging of TMEM (Tumor Microenvironment of Metastasis) in Patients With Operable Breast Cancer

TypeinterventionalSponsorMontefiore Medical CenterRan2018 to 2026Enrolled95ConditionsBreast CancerArmsTMEM-MRI, FNA
3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 118 citations in OpenAlex.

  1. Mena, a new available marker in tumors of salivary glands?European journal of histochemistry : EJH · 2012
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Actin dynamics during tumor cell dissemination.International review of cell and molecular biology · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Frank GertlerDepartment of Biology and Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT), 77 Massachusetts Ave, Cambridge, MA 02138, USA. fgertler@MIT.EDU
John Condeelis
Albert Einstein College of Medicine · USMassachusetts Institute of Technology · US

Funding

Tumor Progression and MetastasisP01CA100324 · NCI · YESHIVA UNIVERSITY · PI CONDEELIS, JOHN S · 2003 to 2018
$30.0M
CELLULAR AND DEVELOPMENTAL FUNCTIONS OF MENAR01GM058801 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GERTLER, FRANK B · 1999 to 2012
$3.8M
Signal transduction regulating tumor cell disseminationR01CA150344 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CONDEELIS, JOHN S · 2010 to 2020
$3.7M
Novel Methods for Detecting Cell Interactions in the Tumor MicroenvironmentU54CA126511 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CONDEELIS, JOHN S · 2006 to 2010
$2.2M
MICROENVIRONMENTS OF INVASION IN HUMAN BREAST TUMORSR01CA113395 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CONDEELIS, JOHN S · 2006 to 2010
$1.4M
NCI NIH HHS 1-U54-CA11296NCI NIH HHS CA100324NCI NIH HHS CA113395NCI NIH HHS CA126511NCI NIH HHS CA150344NCI NIH HHS P01 CA100324NCI NIH HHS R01 CA113395NCI NIH HHS R01 CA150344NCI NIH HHS U54 CA126511NIGMS NIH HHS GM58801NIGMS NIH HHS R01 GM058801
6 · The paper itself

Abstract

During breast cancer metastasis cells emigrate from the primary tumor to the bloodstream, and this carries them to distant sites where they infiltrate and sometimes form metastases within target organs. These cells must penetrate the dense extracellular matrix comprising the basement membrane of the mammary duct/acinus and migrate toward blood and lymphatic vessels, processes that mammary tumor cells execute primarily using epidermal growth factor (EGF)-dependent protrusive and migratory activity. Here, we focus on how the actin regulatory protein Mena affects EGF-elicited movement, invasion and metastasis. Recent findings indicate that, in invasive migratory tumor cells, Mena isoforms that endow heightened sensitivity to EGF and increased protrusive and migratory abilities are upregulated, whereas other isoforms are selectively downregulated. This change in Mena isoform expression enables tumor cells to invade in response to otherwise benign EGF stimulus levels and could offer an opportunity to identify metastatic risk in patients.

Indexed as

Neoplasm MetastasisActinsAnimalsBreast NeoplasmsCell MovementGene Expression ProfilingHumansMicrofilament ProteinsTumor MicroenvironmentActinsEnah protein, humanMicrofilament Proteins

Identifiers

PMID21071226
PMCPMC3402095
OpenAlexW1989168454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.